Cook Medical clearly believes in keeping clinical specialisms separate with the newly announced launch of its new Otolaryngology/Head and Neck Surgery (OHNS) clinical division. OHNS is Cook’s tenth business unit which it anticipates will bring the benefits of the company’s devices for non-surgical procedures to a new group of physicians and the patients they treat.
To date Cook Medical has operated separate divisions to address Aortic Intervention, Critical Care, Endoscopy, Interventional Radiology, Lead Management, Peripheral Intervention, Surgery, Urology and Women’s Health.
Recognising the need for specialised minimally invasive devices in otolaryngology, Cook has formed OHNS to bring together research and development activities in a quest for alternatives to open surgery for treating conditions across several traditional ear, nose and throat (ENT) specialties.
Cook officially unveiled its new clinical division at the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) conference which is taking place in Washington, D.C., this week.
The division’s initial six practice areas of focus are soft tissue repair, salivary gland disease, chronic sinusitis, vocal cord paralysis, obstructive sleep apnea, and interventional airway and oesophageal procedures.
“There is a definite need for true out-of-the-box thinking around minimally invasive medical technology for OHNS,” said Patrick Melder, M.D., of ENT Associates of North Georgia, a paid consultant to Cook Medical and a presenter at the AAO-HNS conference. “Cook Medical has a solid and lengthy track record in innovating minimally invasive technologies, and has the ability to help transform the way we may approach such things as reducing post-tonsillectomy pain or advancing our understanding of the treatment of sinusitis.”
“We started Cook OHNS to pioneer ways to provide patients with diseases affecting the head and neck with less traumatic alternatives to surgeries. As we met with physicians, we heard loud and clear that they saw many opportunities for minimally invasive medical devices in this field,” said Thomas Cherry, global leader for Cook Medical’s OHNS division. “At our core, we’ve always solved problems for clinicians over Cook’s entire history. So now, Cook OHNS is taking proven interventional tools and techniques and applying them to the emerging science of minimally invasive otolaryngology and head and neck surgery.”
“For months, Thomas Cherry kept saying we could help a large group of patients if we could make our products available to them, and he was right. He was doing what Cook has always done; listened to physicians, heard what they needed and given them the tools to treat patients in a better way,” explained Pete Yonkman, executive vice president of strategic business units for Cook Medical.
SOURCE: Cook Medical, Business Wire